Skip to content
Brand AI

Lineage Cell Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Advanced BioMatrix acquires HyStem product line

    Advanced BioMatrix acquired the HyStem line of products from Lineage Cell Therapeutics, including technology, intellectual property, know-how, and assets for manufacturing and selling the products for research and development purposes.

    Source